Archive
Year
Volume(Issue)
Issues
Journal Article
Download
فارسی Version
The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement
bioRxiv
Year:
Volume:
Issue:
Pages:
Citations:
Views:
Downloads:
more
View 39
Interferons and viruses induce a novel primate-specific isoform dACE2 and not the SARS-CoV-2 receptor ACE2
View 19
Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility
View 24
SARSCoV-2 contributes to altering the post-transcriptional regulatory networks across human tissues by sponging RNA binding proteins and micro-RNAs
SARS-Cov-2 Launches a Unique Transcriptional Signature from in Vitro, Ex Vivo, and in Vivo Systems
View 18
SARS-CoV-2 amino acid substitutions widely spread in the human population are mainly located in highly conserved segments of the structural proteins
View 26
Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov
View 84
Molecular mechanism of evolution and human infection with the novel coronavirus (2019-nCoV)
View 46
Inhibition of SARS-CoV-2 infection (previously 2019-nCoV) by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
View 47
Antibody binding to SARS-CoV-2 S glycoprotein correlates with, but does not predict neutralization
View 41
The SARS-CoV-2 S1 spike protein mutation N501Y alters the protein interactions with both hACE2 and human derived antibody: A Free energy of perturbation study
View 23
Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a drug-target interaction deep learning model
View 57
In silico approach to accelerate the development of mass spectrometry-based proteomics methods for detection of viral proteins: Application to COVID-19
View 40
Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China
View 50
A simple magnetic nanoparticles-based viral RNA extraction method for efficient detection of SARS-CoV-2
View 33
SARS-CoV-2 invades host cells via a novel route: CD147-spike protein
View 53
Comparative analysis of primer-probe sets for the laboratory confirmation of SARS-CoV-2
Neural oscillations dissociate between maintenance and proceduralization of novel instructions
SARSCoV-2 detection from nasopharyngeal swab samples without RNA extraction
View 31
The scRNAseq expression profiling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to COVID-19 infection
View 22
In silico Design of novel Multi-epitope recombinant Vaccine based on Coronavirus surface glycoprotein
View 37
A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein
Multivariate Analyses of Codon Usage in 2019 Novel Coronavirus on the Genomic Landscape of Betacoronavirus
Nucleotide analogues as inhibitors of viral polymerases
View 52
Androgen Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
View 61
Functional assessment of cell entry and receptor usage for lineage B β-coronaviruses, including 2019-nCoV
View 78
The potential for SARS-CoV-2 to evade both natural and vaccine induced immunity
View 29
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
View 72
SARS-CoV-2 infection induces EMT-like molecular changes, including ZEB1-mediated repression of the viral receptor ACE2, in lung cancer models
Pangolin homology associated with 2019-nCoV
Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
A SARS-Cov-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing
COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning
View 76
The digestive system is a potential route of 2019-nCov infection: A bioinformatics analysis based on singlecell transcriptomes
View 58
Potent human neutralizing antibodies elicited by SARS-CoV-2 infection
View 32
A systematic review and meta-analysis for association of Helicobacter pylori colonization and celiac disease
View 36
Structure-based drug design, virtual screening and highthroughput screening rapidly identify antiviral leads targeting COVID-19
View 74
Isolation and characterization of 2019-nCoV-like coronavirus from Malayan pangolins
View 81
ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection
Recombination and convergent evolution led to the emergence of 2019 Wuhan coronavirus
Performance of the rapid Nucleic Acid Amplification by Abbott ID NOW COVID-19 in nasopharyngeal swabs transported in viral media and dry nasal swabs, in a New York City academic institution
The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells
View 55
Structure of dimeric fulllength human ACE2 in complex with B0AT1
In silico APC/C substrate discovery reveals cell cycle degradation of chromatin regulators including UHRF1
View 43
A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
View 77
Molecular Modeling Evaluation of the Binding Effect of Ritonavir, Lopinavir and Darunavir to Severe Acute Respiratory Syndrome Coronavirus 2 Proteases
A Rapid COVID-19 RT-PCR Detection Assay for Low Resource Settings
View 38
Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation
Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group
View 54
Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines
Severe acute respiratory syndrome related coronavirus– The species and its viruses, a statement of the Coronavirus Study Group
View 95
Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin
View 88
A oneenzyme RT-qPCR assay for SARS-CoV-2, and procedures for reagent production
A SARSCoV-2 human protein-protein interaction map reveals drug targets and potential drug-repurposing
View 68
Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection
View 70
Teicoplanin potently blocks the cell entry of 2019-nCoV
Viral Architecture of SARSCoV-2 with Post-Fusion Spike Revealed by Cryo-EM
View 49
In-vivo toxicity studies and in-vitro inactivation of SARSCoV-2 by povidone-iodine in-situ gel forming formulations
The S1/S2 boundary of SARS-CoV-2 spike protein modulates cell entry pathways and transmission
View 35
Structure-based drug design, virtual screening and high-throughput screening rapidly identify antiviral leads targeting COVID-19
Comparison of SARS-CoV2 N gene real-time RT-PCR targets and commercially available mastermixes
Time-varying transmission dynamics of Novel Coronavirus Pneumonia in China
Transmission dynamics of 2019 novel coronavirus (2019-nCoV)
View 75
Insights into Cross-species Evolution of Novel Human Coronavirus 2019-nCoV and Defining Immune Determinants for Vaccine Development
Characterization of antiviral immunity in recovered individuals infected by SARS-CoV-2
Increasing host cellular receptorangiotensin-converting enzyme 2 (ACE2) expression by coronavirus may facilitate 2019-nCoV infection
IL-4 receptor targeting as an effective immunotherapy against triple-negative breast cancer
Muscle activity of cutting manoeuvres and soccer inside passing suggests an increased groin injury risk during these movements
View 6
Single-cell analysis of ACE2 expression in human kidneys and bladders reveals a potential route of 2019-nCoV infection
View 42
Reinfection could not occur in SARS-coV-2 infected rhesus macaques